KD-UK has been informed that Initial results from the Phase 2 trial of the experimental drug NIDO-361 have not shown benefits. More details will be published in due course and KD-UK understands that the results will be shared with the KD Community at the International KD conference in Orlando in February.

Although disappointing, the NIDO-361 trial was successful in demonstrating that complex multicentre international KD trials can be delivered.